10-Q: Marpai Reports Q2 2026 Results, Faces Going Concern Doubt

Marpai, Inc. reported its second quarter 2026 financial results, highlighting a continued net loss and significant accumulated deficit, leading to substantial doubt about its ability to continue as a going concern.

Summary

• Marpai, Inc. reported a net loss of $4.6 million for the three months ended June 30, 2026, and $7.8 million for the six months ended June 30, 2026.
• Total revenue decreased by 10.5% to $4.2 million for the three months ended June 30, 2026, and by 14.5% to $8.6 million for the six months ended June 30, 2026, primarily due to customer turnover.
• General and administrative expenses increased by 23.6% for the three months and 9.1% for the six months, driven by investments in labor.
• The company has an accumulated deficit of $123.2 million and negative working capital of $14.5 million as of June 30, 2026.
• Substantial doubt exists about Marpai's ability to continue as a going concern within twelve months from the issuance date of the financial statements.
• Subsequent to the quarter, Marpai raised $12.1 million in gross proceeds from the sale of Series A Preferred Stock.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to the continued net losses, significant accumulated deficit, and substantial doubt about the company's ability to continue as a going concern, despite recent capital raises and operational adjustments.

Positives

• Marpai successfully raised $12.1 million in gross proceeds from the sale of Series A Preferred Stock on July 29, 2026, subsequent to the reporting period.
• The company has taken steps to streamline operations, leading to decreases in information technology and sales and marketing expenses.
• Depreciation and amortization expenses have significantly decreased due to the full depreciation of fixed assets.
• The company repaid $1.0 million of a related party advance on July 9, 2026.

Negatives

• Marpai reported a net loss of $4.6 million for Q2 2026 and $7.8 million for the first six months of 2026.
• Revenue decreased by 10.5% to $4.2 million in Q2 2026 and by 14.5% to $8.6 million for the first six months of 2026, attributed to customer turnover.
• The company has an accumulated deficit of $123.2 million as of June 30, 2026.
• Negative working capital of $14.5 million was reported as of June 30, 2026.
• Substantial doubt exists regarding the company's ability to continue as a going concern.
• Interest expense increased by 50.9% for the three months and 22.6% for the six months, partly due to non-cash adjustments related to the AXA obligation.

Risks

• Continued revenue decline due to customer turnover and market evolution.
• The company's ability to secure additional capital or debt funding to support ongoing operations.
• Potential for significant dilution to existing stockholders from future debt or equity transactions.
• The risk that the company may be forced to scale back operations or divest assets if additional capital cannot be raised.
• Concentration of accounts receivable with a few major customers, posing a risk if these customers terminate agreements.
• Uncertainties related to the ongoing review of strategic alternatives may impact business performance and stock price volatility.
• The company agreed not to incur additional indebtedness other than its currently outstanding indebtedness as part of the AXA Amendment.

Future Outlook

The company projects that it will need additional capital to fund current operations and investment requirements until it reaches revenue levels that permit cash self-sufficiency. Management is seeking to raise additional capital through equity or debt securities, or potentially asset sales. Failure to secure additional capital could materially and adversely impact operations and may force scaling back or divestiture of assets.

Management Comments

• The market is evolving, and we are adapting our approach to better serve our customers needs.
• Management has determined that our liquidity condition raises substantial doubt about our ability to continue as a going concern through twelve months from the date these unaudited interim condensed consolidated financial statements are issued.

Industry Context

StockSavvy.ai notes that Marpai operates in the competitive healthcare administration and TPA market. The reported revenue decline due to customer turnover is a significant concern, as retaining clients is crucial for growth and stability in this sector. The company's focus on a technology-driven service to lower healthcare costs aligns with broader industry trends, but execution and financial stability remain key challenges.

Comparison to Industry Standards

• Marpai's revenue decline contrasts with the general trend of growth in the healthcare administration sector, driven by increasing adoption of value-based care models and employer demand for cost-effective solutions.
• The company's significant accumulated deficit and going concern warning are concerning when compared to established TPA providers who typically demonstrate more stable financial performance and profitability.
• While many TPAs are investing in technology, Marpai's reported increase in G&A expenses alongside revenue decline suggests potential inefficiencies or a lag in translating investments into revenue growth, which is not a standard industry practice for sustainable growth.

Legal Proceedings

• The company settled a civil complaint with Messer Financial Group Inc. for breach of contract, involving cash consideration, restricted shares for attorneys' fees, and installment RSUs over several years, with a potential additional payment if the stock value falls below $1.0 million by January 3, 2028.

Related Party Transactions

• Promissory notes totaling $660 thousand were issued to the Chief Executive Officer in February and March 2026, with maturity dates extended to September 1, 2026, and were fully repaid by June 22, 2026.
• Interest expense of $18 thousand and $26 thousand was recorded for these promissory notes in the three and six months ended June 30, 2026, respectively.
• The company received a $500 thousand advance payment from a related party for future TPA services on April 29, 2026.
• Marpai recognized $183 thousand of related-party revenue in each of the three and six months ended June 30, 2026.
• A $1.0 million refundable cash advance was received from a related party on May 13, 2026, and repaid in full on July 9, 2026.

Stakeholder Impact

• Existing stockholders face potential dilution from future equity or debt financing.
• The going concern warning may impact investor confidence and the company's ability to attract and retain qualified personnel.
• Customers may be concerned about the company's financial stability and its ability to provide ongoing services.
• Creditors and lenders face increased risk due to the company's liquidity challenges and going concern status.

Next Steps

• Continue to adapt approach to better serve customer needs.
• Seek additional capital through equity or debt issuance, or asset sales.
• Manage operations and investments to achieve revenue levels permitting cash self-sufficiency.
• Address the substantial doubt about the company's ability to continue as a going concern.

Key Dates

Recommendation

The company's persistent net losses, significant accumulated deficit, negative working capital, and the explicit statement of substantial doubt about its ability to continue as a going concern, despite a recent capital raise, indicate a high level of financial distress. The ongoing revenue decline and increased G&A expenses further exacerbate these concerns. While the capital raise provides some short-term relief, the fundamental issues remain unresolved, making the stock a sell.

Keywords

Third-Party Administrator, Healthcare Administration, Self-Insured Employers, TPA Services, Healthcare Technology, Managed Care, Employee Benefits, Financial Reporting